Drug – bio-affecting and body treating compositions – Immunoglobulin – antiserum – antibody – or antibody fragment,... – Reduced antigenicity – reduced ability to bind complement – or...
Patent
1983-08-12
1984-12-25
Phillips, Delbert R.
Drug, bio-affecting and body treating compositions
Immunoglobulin, antiserum, antibody, or antibody fragment,...
Reduced antigenicity, reduced ability to bind complement, or...
2601125R, 2601125LH, A61K 3700, C07C10352
Patent
active
044903642
ABSTRACT:
Analogs of CCK(1-8) having dissociated activity with respect to stimulating the contraction of the gall bladder and arresting the secretion of gastric acid. Various analogs also exhibit improved anticonvulsive potency. The peptides are characterized by the following formula:
REFERENCES:
patent: 4330466 (1982-05-01), Yanaihara et al.
patent: 4351829 (1982-09-01), Zetler et al.
Penke Botond
Rivier Jean E. F.
Phillips Delbert R.
The Salk Institute for Biological Studies
LandOfFree
CCK Agonists II does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with CCK Agonists II, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and CCK Agonists II will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1152406